Literature DB >> 8896582

Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.

J Capala1, M S Makar, J A Coderre.   

Abstract

The short (< 10 microns) ranges of alpha and 7Li particles produced during boron neutron capture therapy (BNCT) make the partitioning of the boronated drug within and without the cell of critical importance. The evaluation of the potential usefulness of a boron-containing substance for BNCT requires information about its intracellular accumulation. In the present report, an in vitro method is described for direct measurement of intracellular boron based on rapid centrifugation of cells through a layer of mineral oil and silicon oil to strip away extracellular growth medium. The intracellular concentrations of boronophenylalanine (BPA), mercaptoborane (BSH) and horic acid in malignant cells and in normal cells have been compared. The accumulation ratio is defined as the ratio of the intracellular to the extracellular boron concentration. Boric acid showed an accumulation ratio of 1 while the ratios for BSH and BPA were dependent on cell type and tended to be greater for BPA than for BSH in malignant but not in normal cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896582

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Boron neutron capture enhancement (BNCE) of fast neutron irradiation for glioblastoma: increase of thermal neutron flux with heavy material collimation, a theoretical evaluation.

Authors:  P Paquis; J P Pignol; M Lonjon; N Brassart; A Courdi; P Chauvel; P Grellier; M Chatel
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.

Authors:  A Tommy Bergenheim; Jacek Capala; Michael Roslin; Roger Henriksson
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

3.  Clinical Use of Radiopharmaceuticals in Boron Neutron Capture Therapy.

Authors:  Yun-Sang Lee; Hyo Jung Seo
Journal:  Nucl Med Mol Imaging       Date:  2022-03-14

4.  Accumulation of boron in human malignant glioma cells in vitro is cell type dependent.

Authors:  Maria Dahlström; Jacek Capala; Peter Lindström; Ake Wasteson; Annelie Lindström
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

5.  Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy.

Authors:  Gianni Ciofani; Vittoria Raffa; Arianna Menciassi; Alfred Cuschieri
Journal:  Nanoscale Res Lett       Date:  2008-11-25       Impact factor: 4.703

6.  Microdosimetric Modeling of Biological Effectiveness for Boron Neutron Capture Therapy Considering Intra- and Intercellular Heterogeneity in 10B Distribution.

Authors:  Tatsuhiko Sato; Shin-Ichiro Masunaga; Hiroaki Kumada; Nobuyuki Hamada
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.